R-(−)-Fluoxetine hydrochloride
SIGMA/F1678 - >98% (HPLC), solid
Synonym: (R)-N-
CAS Number: 114247-09-5
Empirical Formula (Hill Notation): C17H18NOF3 · HCl
Molecular Weight: 345.79
MDL Number: MFCD04040065
Linear Formula: C17H18NOF3 · HCl
Product Type: Chemical
| assay | >98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/C17H18F3NO.ClH/c1-21-1 |
| InChI key | GIYXAJPCNFJEHY-PKLMIRHRSA |
| originator | Eli Lilly |
| Quality Level | 100 ![]() |
| SMILES string | Cl[H].CNCC[C@@H](Oc1ccc(c |
| solubility | H2O: soluble >10 mg/mL |
| storage condition | desiccated |
| Application: | R-(−)-Fluoxetine hydrochloride has been used as a serotonin reuptake inhibitor: • to study its effects on the embryoid body (EB) morphogenesis • in combination with muscimol hydrobromide (MUS) as well as individually to study its neurotoxic effects on neuronal cells grown on multielectrode array (MEA) chips • to study its effects as an endocrine disruption inducer in Pimephales promelas |
| Biochem/physiol Actions: | Fluoxetine exhibits anti-depressant activity by increasing the serotonin levels in the neuron synaptic space. It also exhibits therapeutic effects against depression and other mood disorders. |
| Biochem/physiol Actions: | Selective serotonin reuptake inhibitor. |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302 - H315 - H318 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 + P310 |
| Hazard Codes | Xn |
| Risk Statements | 22-38-41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | >98% (HPLC) |
| UNSPSC | 12352200 |



